Flexion Therapeutics
FLXN
$9.12
Share price
0.00%
Change (1 day)
8,190.91%
Change (1 year)
Categories
Market capitalization of Flexion Therapeutics (FLXN)
Market cap: $0.45 Billion
As of April 2024 Flexion Therapeutics has a market cap of $0.45 Billion. This makes Flexion Therapeutics the world's 6059th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Flexion Therapeutics from 2014 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.45 B | 0% |
| 2021 | $0.45 B | -19.5% |
| 2020 | $0.57 B | -28.21% |
| 2019 | $0.79 B | 84.86% |
| 2018 | $0.42 B | -54.3% |
| 2017 | $0.94 B | 56.07% |
| 2016 | $0.60 B | 44.9% |
| 2015 | $0.41 B | -3.98% |
| 2014 | $0.43 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $353.80 B | 76,993.03% | 🇺🇸 USA |
 Pfizer PFE | $143.03 B | 31,067.15% | 🇺🇸 USA |
 Recro Pharma
REPH | $0.12 B | -73.15% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $1.18 B | 158.50% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $14.57 M | -96.82% | 🇺🇸 USA |
 Ampio Pharmaceuticals AMPE | $0.39 M | -99.91% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $38.26 M | -91.66% | 🇺🇸 USA |